These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 2151294

  • 1. [3H]vesamicol binding in human brain cholinergic deficiency disorders.
    Kish SJ, Distefano LM, Dozic S, Robitaille Y, Rajput A, Deck JH, Hornykiewicz O.
    Neurosci Lett; 1990 Sep 18; 117(3):347-52. PubMed ID: 2151294
    [Abstract] [Full Text] [Related]

  • 2. Choline acetyltransferase activity and vesamicol binding in Rett syndrome and in rats with nucleus basalis lesions.
    Wenk GL, Mobley SL.
    Neuroscience; 1996 Jul 18; 73(1):79-84. PubMed ID: 8783231
    [Abstract] [Full Text] [Related]

  • 3. Choline acetyltransferase activity and [3H]vesamicol binding in the temporal cortex of patients with Alzheimer's disease, Parkinson's disease, and rats with basal forebrain lesions.
    Ruberg M, Mayo W, Brice A, Duyckaerts C, Hauw JJ, Simon H, LeMoal M, Agid Y.
    Neuroscience; 1990 Jul 18; 35(2):327-33. PubMed ID: 2166243
    [Abstract] [Full Text] [Related]

  • 4. [3H]vesamicol binding in brain: autoradiographic distribution, pharmacology, and effects of cholinergic lesions.
    Altar CA, Marien MR.
    Synapse; 1988 Jul 18; 2(5):486-93. PubMed ID: 2973145
    [Abstract] [Full Text] [Related]

  • 5. Autoradiographic comparison of [3H](-)nicotine, [3H]cytisine and [3H]epibatidine binding in relation to vesicular acetylcholine transport sites in the temporal cortex in Alzheimer's disease.
    Sihver W, Gillberg PG, Svensson AL, Nordberg A.
    Neuroscience; 1999 Jul 18; 94(3):685-96. PubMed ID: 10579560
    [Abstract] [Full Text] [Related]

  • 6. Vesamicol receptor mapping of brain cholinergic neurons with radioiodine-labeled positional isomers of benzovesamicol.
    Jung YW, Frey KA, Mulholland GK, del Rosario R, Sherman PS, Raffel DM, Van Dort ME, Kuhl DE, Gildersleeve DL, Wieland DM.
    J Med Chem; 1996 Aug 16; 39(17):3331-42. PubMed ID: 8765517
    [Abstract] [Full Text] [Related]

  • 7. Regional brain 5-hydroxytryptamine levels are reduced in senile Down's syndrome as in Alzheimer's disease.
    Yates CM, Simpson J, Gordon A.
    Neurosci Lett; 1986 Apr 11; 65(2):189-92. PubMed ID: 2940479
    [Abstract] [Full Text] [Related]

  • 8. Quantitative autoradiography of brain binding sites for the vesicular acetylcholine transport blocker 2-(4-phenylpiperidino)cyclohexanol (AH5183).
    Marien MR, Parsons SM, Altar CA.
    Proc Natl Acad Sci U S A; 1987 Feb 11; 84(3):876-80. PubMed ID: 3468515
    [Abstract] [Full Text] [Related]

  • 9. Synthesis of radioiodinated analogs of 2-(4-phenylpiperidino)cyclohexanol (vesamicol) as vesamicol-like agent.
    Shiba K, Mori H, Matsuda H, Tsuji S, Kuji I, Sumiya H, Kinuya K, Tonami N, Hisada K, Sumiyosi T.
    Nucl Med Biol; 1995 Feb 11; 22(2):205-10. PubMed ID: 7767314
    [Abstract] [Full Text] [Related]

  • 10. Effects of systemic administration of 2-(4-phenyl-piperidino)-cyclohexanol (vesamicol) and an organophosphate DDVP on the cholinergic system in brain regions of rats.
    Kobayashi H, Watanabe T, Yasufuku T, Suzuki T, Saitoh S, Takeno K.
    Brain Res Bull; 1997 Feb 11; 43(1):17-23. PubMed ID: 9205789
    [Abstract] [Full Text] [Related]

  • 11. Reduced cerebral cortical but elevated striatal concentration of somatostatin-like immunoreactivity in dominantly inherited olivopontocerebellar atrophy.
    Kish SJ, Robitaille Y, el-Awar M, Schut L, DiStefano L, Ball MJ, Mazurek MF.
    J Neurol Neurosurg Psychiatry; 1993 Sep 11; 56(9):1013-5. PubMed ID: 8105030
    [Abstract] [Full Text] [Related]

  • 12. The pharmacology of vesamicol: an inhibitor of the vesicular acetylcholine transporter.
    Prior C, Marshall IG, Parsons SM.
    Gen Pharmacol; 1992 Nov 11; 23(6):1017-22. PubMed ID: 1487110
    [Abstract] [Full Text] [Related]

  • 13. Overexpression of the high affinity choline transporter in cortical regions affected by Alzheimer's disease. Evidence from rapid autopsy studies.
    Slotkin TA, Nemeroff CB, Bissette G, Seidler FJ.
    J Clin Invest; 1994 Aug 11; 94(2):696-702. PubMed ID: 8040324
    [Abstract] [Full Text] [Related]

  • 14. Non-Alzheimer-type pattern of brain cholineacetyltransferase reduction in dominantly inherited olivopontocerebellar atrophy.
    Kish SJ, Robitaille Y, el-Awar M, Deck JH, Simmons J, Schut L, Chang LJ, DiStefano L, Freedman M.
    Ann Neurol; 1989 Sep 11; 26(3):362-7. PubMed ID: 2802535
    [Abstract] [Full Text] [Related]

  • 15. In favour of the vesicular hypothesis: neurochemical evidence that vesamicol (AH5183) inhibits stimulation-evoked release of acetylcholine from neuromuscular junction.
    Vizi ES.
    Br J Pharmacol; 1989 Nov 11; 98(3):898-902. PubMed ID: 2590773
    [Abstract] [Full Text] [Related]

  • 16. Effects of chronic basic fibroblast growth factor administration to rats with partial fimbrial transections on presynaptic cholinergic parameters and muscarinic receptors in the hippocampus: comparison with nerve growth factor.
    Araujo DM, Lapchak PA, Hefti F.
    J Neurochem; 1993 Sep 11; 61(3):899-910. PubMed ID: 8360689
    [Abstract] [Full Text] [Related]

  • 17. Interactions between the effects of basal forebrain lesions and chronic treatment with MDL 26,479 on learning and markers of cholinergic transmission.
    Holley LA, Miller JA, Chmielewski PA, Dudchenko P, Sarter M.
    Brain Res; 1993 May 07; 610(2):181-93. PubMed ID: 8391369
    [Abstract] [Full Text] [Related]

  • 18. Vesamicol and some of its derivatives: questionable ligands for selectively labelling acetylcholine transporters in rat brain.
    Custers FG, Leysen JE, Stoof JC, Herscheid JD.
    Eur J Pharmacol; 1997 Nov 05; 338(2):177-83. PubMed ID: 9456000
    [Abstract] [Full Text] [Related]

  • 19. Brain choline acetyltransferase reduction in dominantly inherited olivopontocerebellar atrophy.
    Kish SJ, Currier RD, Schut L, Perry TL, Morito CL.
    Ann Neurol; 1987 Aug 05; 22(2):272-5. PubMed ID: 3477997
    [Abstract] [Full Text] [Related]

  • 20. Degeneration of the cholinergic innervation of the locus ceruleus in Alzheimer's disease.
    Strong R, Huang JS, Huang SS, Chung HD, Hale C, Burke WJ.
    Brain Res; 1991 Feb 22; 542(1):23-8. PubMed ID: 2054656
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.